HHS Secretary Xavier Becerra similarly called for a review of the increase Jan. 10 following the announcement that Biogen would cut the price of its Alzehimer’s drug. CMS cited the potential need to cover the drug as one of the reasons for the premium hike.
The lawmakers echoed Mr. Becerra’s sentiments, and said that the premium increase threatens seniors who are already struggling to afford healthcare costs. The letter also urged CMS to take further actions to combat rising prescription drug costs.
“Much like President Biden, we promised to reduce prescription drug costs – particularly for older Americans,” the letter read. “We cannot break our promise to the American people.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
